NSC |
Compound |
Enrichment |
Correlation |
NSC 685794 |
Null |
0.00163653239752573 |
0.14245419 |
NSC 697569 |
Null |
0.00163653239752573 |
0.37260238 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.00163653239752573 |
0.34343948 |
NSC 730460 |
16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate |
0.00163653239752573 |
0.3261955 |
NSC 731155 |
6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt |
0.00163653239752573 |
0.2102733 |
NSC 251805 |
Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester |
0.00172065213317242 |
0.068575128 |
NSC 638646 |
4-Piperidinone, 3,5-bis[(3,4-dichlorophenyl)methylene]- 1-[3-(4-morpholinyl)-1-oxopropyl]-, monohydrochloride |
0.00172065213317242 |
0.38998439 |
NSC 639978 |
Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride |
0.00172065213317242 |
0.29881552 |
NSC 680781 |
2(3H)-Furanone, dihydro-3-[1-[(4-chlorophenyl)amino] ethylidene]- |
0.00172065213317242 |
0.33383668 |
NSC 762934 |
Null |
0.00172065213317242 |
-0.32848336 |